Omniome Company Profile: Funding, Investors & Partnerships

Omniome

Omniome is developing a breakthrough DNA sequencing platform capable of delivering unsurpassed sequencing accuracy with the potential to advance cancer diagnostics, drive high fidelity single-cell applications and broadly support clinical sequencing. Our proprietary scar-free sequencing biochemistry and technology provides enhanced precision and flexibility. Omniome is developing a breakthrough DNA sequencing platform capable of delivering unsurpassed seque Show More

Alpha Score

45.3

Total Funding$ 120.00 M